Skip to content 
Parkinson’s disease
Parkinson’s disease is a progressive brain disorder that affects movement and daily life. While current treatments help manage symptoms, research is driving new therapies and moving toward earlier detection and prevention. Discover how we are changing the future of Parkinson’s disease.
LEARN MORE ABOUT PD
Our clinical studies
Clinical trials, or clinical studies, are research studies designed to evaluate the effects of new therapies or interventions. They are conducted in different phases, each aimed at answering specific scientific and safety-related questions. Before they begin, clinical trials are carefully designed, reviewed, and approved, and they follow strict regulations to ensure participants’ safety and confidentiality.
STUDIES ON PD
Aim to improve diagnosis and treatment for people living with PD by testing and developing clinical biomarkers and novel treatments.
LEARN MORE
PREVENTION STUDIES
Focus on prevention of neurodegenerative diseases. These recruit individuals who do not have a PD diagnosis, but are at increased risk.
LEARN MORE
PLATFORM STUDIES
SLEIPNIR; a pioneering platform that will test multiple compounds for target engagement in parallel, advancing the most promising candidates to HYDRA, our phase III platform trial.
LEARN MORE
